Michael Wegmann

3.4k total citations
67 papers, 2.4k citations indexed

About

Michael Wegmann is a scholar working on Physiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Wegmann has authored 67 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Physiology, 28 papers in Immunology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Wegmann's work include Asthma and respiratory diseases (44 papers), IL-33, ST2, and ILC Pathways (18 papers) and Pediatric health and respiratory diseases (10 papers). Michael Wegmann is often cited by papers focused on Asthma and respiratory diseases (44 papers), IL-33, ST2, and ILC Pathways (18 papers) and Pediatric health and respiratory diseases (10 papers). Michael Wegmann collaborates with scholars based in Germany, United States and Austria. Michael Wegmann's co-authors include Heinz Fehrenbach, Christina Wagner, Lars Lunding, Holger Garn, Harald Renz, Harald Renz, Udo Herz, Christina Vock, S. Sel and Nicole Blümer and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Michael Wegmann

67 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Wegmann Germany 27 1.1k 907 625 405 368 67 2.4k
Ian Sayers United Kingdom 25 1.3k 1.2× 862 1.0× 795 1.3× 455 1.1× 339 0.9× 95 2.5k
Max A. Seibold United States 30 914 0.8× 735 0.8× 1.1k 1.7× 640 1.6× 350 1.0× 77 2.7k
Delphine Gras France 23 867 0.8× 561 0.6× 625 1.0× 430 1.1× 280 0.8× 54 2.0k
Akihiro Oshiba United States 16 1.8k 1.6× 1.0k 1.1× 734 1.2× 309 0.8× 832 2.3× 29 2.7k
Andrew J. Sandford Canada 32 1.4k 1.3× 725 0.8× 1.5k 2.3× 950 2.3× 348 0.9× 104 3.7k
Emiko Noguchi Japan 33 1.6k 1.4× 1.0k 1.1× 478 0.8× 728 1.8× 859 2.3× 119 3.5k
Naomi Yamashita Japan 26 617 0.6× 1.1k 1.2× 389 0.6× 413 1.0× 497 1.4× 91 2.6k
Isabelle Vachier France 32 1.8k 1.6× 644 0.7× 1.5k 2.5× 514 1.3× 473 1.3× 120 3.3k
Jeremy A. Hirota Canada 32 1.0k 0.9× 946 1.0× 900 1.4× 840 2.1× 190 0.5× 97 3.2k
Angela Haczku United States 40 2.1k 1.9× 1.7k 1.9× 1.4k 2.2× 445 1.1× 595 1.6× 105 4.3k

Countries citing papers authored by Michael Wegmann

Since Specialization
Citations

This map shows the geographic impact of Michael Wegmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wegmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wegmann more than expected).

Fields of papers citing papers by Michael Wegmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wegmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wegmann. The network helps show where Michael Wegmann may publish in the future.

Co-authorship network of co-authors of Michael Wegmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wegmann. A scholar is included among the top collaborators of Michael Wegmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wegmann. Michael Wegmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ritzmann, Felix, et al.. (2025). Role of Epigenetics in Chronic Lung Disease. Cells. 14(4). 251–251. 2 indexed citations
2.
Lunding, Lars, Guido Stichtenoth, Cordula Stamme, et al.. (2021). LAMP3 deficiency affects surfactant homeostasis in mice. PLoS Genetics. 17(6). e1009619–e1009619. 9 indexed citations
3.
Vella, Giovanna, Lars Lunding, Felix Ritzmann, et al.. (2020). The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma. Respiratory Research. 21(1). 176–176. 8 indexed citations
4.
Højen, Jesper Falkesgaard, Amy S. McKee, Tania Azam, et al.. (2019). IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease. Nature Immunology. 20(9). 1138–1149. 65 indexed citations
5.
Wegmann, Michael, Lars Lunding, Christina Vock, et al.. (2018). Tumstatin fragment selectively inhibits neutrophil infiltration in experimental asthma exacerbation. Clinical & Experimental Allergy. 48(11). 1483–1493. 17 indexed citations
6.
Lunding, Lars, Christina Vock, Alexandra Schröder, et al.. (2016). Effect of IL-37 on Allergic Airway Inflammation. Annals of the American Thoracic Society. 13(Supplement_1). S95–S96. 11 indexed citations
7.
Lunding, Lars, Christina Vock, A. Schröder, et al.. (2015). IL-37 requires IL-18Rα and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice. Allergy. 70(4). 366–373. 118 indexed citations
8.
Wegmann, Michael. (2011). Targeting Eosinophil Biology in Asthma Therapy. American Journal of Respiratory Cell and Molecular Biology. 45(4). 667–674. 50 indexed citations
9.
Luger, Elke, Michael Wegmann, Gernot Achatz, et al.. (2009). Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. Journal of Allergy and Clinical Immunology. 124(4). 819–826.e4. 85 indexed citations
10.
Wegmann, Michael, Elke Luger, Sebastian Kerzel, et al.. (2009). Nerve Growth Factor and Neurotrophin-3 Mediate Survival of Pulmonary Plasma Cells during the Allergic Airway Inflammation. The Journal of Immunology. 182(8). 4705–4712. 40 indexed citations
11.
Paragh, György, Petra Schling, Péter Ugocsai, et al.. (2008). Novel sphingolipid derivatives promote keratinocyte differentiation. Experimental Dermatology. 17(12). 1004–1016. 18 indexed citations
12.
Sel, Serdar, Michael Wegmann, Tanja Dicke, et al.. (2008). Effective prevention and therapy of experimental allergic asthma using a GATA-3–specific DNAzyme. Journal of Allergy and Clinical Immunology. 121(4). 910–916.e5. 82 indexed citations
13.
Wegmann, Michael. (2008). Th2 cells as targets for therapeutic intervention in allergic bronchial asthma. Expert Review of Molecular Diagnostics. 9(1). 85–100. 67 indexed citations
14.
Wegmann, Michael & Harald Renz. (2006). Animal Models of Experimental Asthma. PubMed. 69–87. 8 indexed citations
15.
Wegmann, Michael, Rolf Göggel, S. Sel, et al.. (2006). Effects of a Low-Molecular-Weight CCR-3 Antagonist on Chronic Experimental Asthma. American Journal of Respiratory Cell and Molecular Biology. 36(1). 61–67. 73 indexed citations
16.
Beißwenger, Christoph, C. Hess, Holger Garn, et al.. (2006). Allergic Airway Inflammation Inhibits Pulmonary Antibacterial Host Defense. The Journal of Immunology. 177(3). 1833–1837. 102 indexed citations
17.
Wegmann, Michael, S. Sel, Klaus J. Erb, et al.. (2006). Therapy of Established Chronic Experimental Asthma with a Low Molecular Weight Ccr-3 Antagonist. Journal of Allergy and Clinical Immunology. 117(2). S276–S276. 1 indexed citations
18.
Stech, Jürgen, et al.. (2005). A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin. Nature Medicine. 11(6). 683–689. 65 indexed citations
19.
Wegmann, Michael, Antonia Fehrenbach, Heinz Fehrenbach, et al.. (2005). NO2-induced airway inflammation is associated with progressive airflow limitation and development of emphysema-like lesions in C57BL/6 mice. Experimental and Toxicologic Pathology. 56(6). 341–350. 48 indexed citations
20.
Wegmann, Michael, Heinz Fehrenbach, Antonia Fehrenbach, et al.. (2005). Involvement of distal airways in a chronic model of experimental asthma. Clinical & Experimental Allergy. 35(10). 1263–1274. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian Sayers Breakdown of academic impact, for papers by Max A. Seibold Breakdown of academic impact, for papers by Delphine Gras Breakdown of academic impact, for papers by Akihiro Oshiba Breakdown of academic impact, for papers by Andrew J. Sandford Breakdown of academic impact, for papers by Emiko Noguchi Breakdown of academic impact, for papers by Naomi Yamashita Breakdown of academic impact, for papers by Isabelle Vachier Breakdown of academic impact, for papers by Jeremy A. Hirota Breakdown of academic impact, for papers by Angela Haczku
Rankless by CCL
2026